PE71799A1 - Derivados de benzoxazindiona, aplicacion de los mismos y medicamentos que los contienen - Google Patents

Derivados de benzoxazindiona, aplicacion de los mismos y medicamentos que los contienen

Info

Publication number
PE71799A1
PE71799A1 PE1998000152A PE00015298A PE71799A1 PE 71799 A1 PE71799 A1 PE 71799A1 PE 1998000152 A PE1998000152 A PE 1998000152A PE 00015298 A PE00015298 A PE 00015298A PE 71799 A1 PE71799 A1 PE 71799A1
Authority
PE
Peru
Prior art keywords
alkyl
formula
cor9
halogen
radical
Prior art date
Application number
PE1998000152A
Other languages
English (en)
Inventor
Lothar Heinisch
Ute Mollmann
Rolf Reissbrodt
Steffen Wittmann
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE71799A1 publication Critical patent/PE71799A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I) O SU ESTER, DONDE R1 ES H, CO-ALQUILO o COO-ALQUILO; R2 ES H, ALQUILO, HALOGENO; R3 ES a)Z-CHR4-COR5, Z ES UN GRUPO DE FORMULA (a), R4 ES (CH2)nCOX, PARTICULARMENTE HIDROXIFENILO O ACILOXIFENILO, n ES 1-10; R4 ES (CH2)n-Y; Y ES UNA BENZOXAZINDIONA DE FORMULA (b); R5 ES NH.CHR8-COR9 o -NH-CH(COX)-(CH2)n-Y; R6 ES H, ALQUILO, HALOGENO; R7 ES H o ACILO; m ES 1-2; b)R3 ES CHR4-COR5; c)UN RADICAL DE FORMULA R18; R12 ES H, ALQUILO, HALOGENO, OH, -N(R15)CO-(CHR14)n-, ENTRE OTROS; R14 Y R15 SON R1 Y R2; d)R3 ES -(CH2)p-FENILOSUSTITUIDO POR COR9 Y R13; R13 ES H, ALQUILO, HALOGENO, ENTRE OTROS; p ES 0-2; e)R3 ES UN GRUPO DE FORMULA -N=C(R16)(-FENILO-COR9) o -N=C(R16)(COR9); R4, R8, R10, R11, R16 SON H, ALQUILO, FENILO OPCIONALMENTE SUSTITUIDO; f)R3 o X o R5 o R9 SON OA, UN RADICAL DE SUSTANCIA ACTIVA, UN RADICAL DE UN ANTIBIOTICO LIGADO A TRAVES DE OH; A ES H. ALQUILO, UN ION METAL ALCALINO, ION AMONIO OPCIONALMENTE SUSTITUIDO. SON COMPUESTOS PREFERIDOS ACIDO (8-METOXICARBONILOXI-2,4-DIOXO-BENZOXAZIN-3IL)ACETICO; N-(8-METOXICARBONILOXI-2,4-DIOXO-BENZOXAZIN-3-IL-ACETIL)-AMPICILINA, ENTRE OTROS. EL COMPUESTO DE FORMULA (I) PUEDE SER UTIL COMO TERAPEUTICO EN INFECCIONES BACTERIANAS O PERTURBACIONES DEL METABOLISMO DEL FIERRO
PE1998000152A 1997-03-05 1998-03-04 Derivados de benzoxazindiona, aplicacion de los mismos y medicamentos que los contienen PE71799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19708846A DE19708846A1 (de) 1997-03-05 1997-03-05 Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
PE71799A1 true PE71799A1 (es) 1999-08-07

Family

ID=7822233

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000152A PE71799A1 (es) 1997-03-05 1998-03-04 Derivados de benzoxazindiona, aplicacion de los mismos y medicamentos que los contienen

Country Status (30)

Country Link
US (1) US6013647A (es)
EP (1) EP0863139B1 (es)
JP (1) JPH10316666A (es)
KR (1) KR19980079905A (es)
CN (1) CN1075064C (es)
AR (1) AR010125A1 (es)
AT (1) ATE200080T1 (es)
AU (1) AU737760B2 (es)
BR (1) BR9802894A (es)
CA (1) CA2230965A1 (es)
CO (1) CO4950613A1 (es)
CZ (1) CZ65098A3 (es)
DE (2) DE19708846A1 (es)
DK (1) DK0863139T3 (es)
ES (1) ES2157617T3 (es)
GR (1) GR3035834T3 (es)
HK (1) HK1015763A1 (es)
HU (1) HUP9800472A3 (es)
IL (1) IL123535A (es)
NO (1) NO310657B1 (es)
NZ (1) NZ329883A (es)
PE (1) PE71799A1 (es)
PL (1) PL325142A1 (es)
PT (1) PT863139E (es)
RU (1) RU2184114C2 (es)
SI (1) SI0863139T1 (es)
SK (1) SK28898A3 (es)
UA (1) UA45414C2 (es)
UY (1) UY24915A1 (es)
ZA (1) ZA981847B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6115157A (en) * 1997-12-24 2000-09-05 Nortel Networks Corporation Methods for equalizing WDM systems
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
DE10111164A1 (de) * 2001-03-01 2002-09-05 Gruenenthal Gmbh Neue substituierte Catecholderivate abgeleitet von mehrbasischen sekundären Aminosäuren, Verfahren zu ihrer Herstellung und ihre Anwendung
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
WO2006126171A2 (en) 2005-05-25 2006-11-30 Actelion Pharmaceuticals Ltd New antibiotic derivatives
TWI603962B (zh) * 2016-09-10 2017-11-01 國立清華大學 含硫噁嗪化合物及其合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047573A (en) * 1962-07-31 N-alkylamido substituted
FR831710A (fr) * 1937-02-02 1938-09-13 Procédé de fabrication de fermetures à tirette, à partir de matière non métallique
DE1147583B (de) * 1959-07-01 1963-04-25 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden
GB878603A (en) * 1959-07-01 1961-10-04 Nippon Shinyaku Co Ltd Salicyclic acid derivatives
US4338436A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
US4319028A (en) * 1976-08-26 1982-03-09 Eli Lilly And Company 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
DE4102234A1 (de) * 1991-01-23 1992-07-30 Dresden Arzneimittel Neue (alpha)-aminochinolinoyl-(3)-penicilline, verfahren zu deren herstellung und diese enthaltende antibakterielle mittel
IT1256023B (it) * 1992-06-10 1995-11-20 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
DE19654920A1 (de) * 1996-06-26 1998-01-08 Gruenenthal Gmbh Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
CZ65098A3 (cs) 1998-09-16
AU5645598A (en) 1998-09-10
PT863139E (pt) 2001-07-31
AR010125A1 (es) 2000-05-17
NZ329883A (en) 1999-04-29
PL325142A1 (en) 1998-09-14
US6013647A (en) 2000-01-11
ES2157617T3 (es) 2001-08-16
EP0863139A1 (de) 1998-09-09
HUP9800472A3 (en) 2000-09-28
DE19708846A1 (de) 1998-09-17
HU9800472D0 (en) 1998-04-28
UY24915A1 (es) 2000-12-29
NO980929D0 (no) 1998-03-04
UA45414C2 (uk) 2002-04-15
AU737760B2 (en) 2001-08-30
CN1195664A (zh) 1998-10-14
KR19980079905A (ko) 1998-11-25
ATE200080T1 (de) 2001-04-15
CN1075064C (zh) 2001-11-21
JPH10316666A (ja) 1998-12-02
NO310657B1 (no) 2001-08-06
CO4950613A1 (es) 2000-09-01
IL123535A (en) 2000-10-31
RU2184114C2 (ru) 2002-06-27
SI0863139T1 (en) 2001-06-30
CA2230965A1 (en) 1998-09-05
DE59800568D1 (de) 2001-05-03
GR3035834T3 (en) 2001-08-31
NO980929L (no) 1998-09-07
SK28898A3 (en) 1998-11-04
EP0863139B1 (de) 2001-03-28
ZA981847B (en) 1998-09-08
HUP9800472A2 (hu) 1999-06-28
IL123535A0 (en) 1998-10-30
HK1015763A1 (en) 1999-10-22
BR9802894A (pt) 2000-03-21
DK0863139T3 (da) 2001-04-30

Similar Documents

Publication Publication Date Title
DK0992501T3 (da) Pyridoncarboxylsyre derivater som antibakterielle midler
ATE205479T1 (de) Naphtalen-derivate als prostaglandin i2 agonisten
NZ506679A (en) HIV inhibiting pyrimidine derivatives
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
DE59308619D1 (de) Germicide wirkstoffkombinationen
ES2052387T3 (es) Utilizacion de derivados de pirimidina-3-oxido para frenar la caida de los cabellos y composiciones topicas empleadas.
EA199901016A1 (ru) 9-оксим-производные эритромицина
NO883487D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
BR0014199A (pt) Derivados de bifenila como inibidores de nhe-3
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
PE71799A1 (es) Derivados de benzoxazindiona, aplicacion de los mismos y medicamentos que los contienen
PE20011349A1 (es) 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
DE69619259T2 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
DK0660822T3 (da) Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DE69813886D1 (de) Naphthalin derivate
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
TR200103212T2 (tr) Mantar ilacı olarak kullanılan eterler
ES461973A1 (es) Procedimiento para la preparacion de benzamidatos.
NO20000114D0 (no) 2,4,4-trisubstituerte-1,3-diokolan-antifungale midler
ATE172724T1 (de) Anthelmintische benzimidazole
AR006754A1 (es) Derivados de quinoxalina utiles en terapia
ES2132255T3 (es) Nuevos compuestos de flavilio farmaceuticamente activos.
AR018002A1 (es) Composicion farmaceutica que comprende un anticonvulsivo y una resina de intercambio ionico para el tratamiento de la epilepsia, compuestos, uso de lapirrolidona polivinilica y proceso para preparar la composicion

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed